156 related articles for article (PubMed ID: 36572102)
21. Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score.
Klapproth CP; Fischer F; Rose M; Karsten MM
J Clin Epidemiol; 2022 Dec; 152():101-109. PubMed ID: 36162712
[TBL] [Abstract][Full Text] [Related]
22. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
[TBL] [Abstract][Full Text] [Related]
23. Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health States.
Gamper EM; Holzner B; King MT; Norman R; Viney R; Nerich V; Kemmler G
Value Health; 2018 Aug; 21(8):958-966. PubMed ID: 30098674
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
[TBL] [Abstract][Full Text] [Related]
25. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Pilz MJ; Seyringer S; Hallsson LR; Bottomley A; Jansen F; King MT; Norman R; Rutten MJ; Leeuw IMV; Siersema PD; Gamper EM
Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38483665
[TBL] [Abstract][Full Text] [Related]
26. EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population.
Young T; Velikova G; Liegl G; Rose M; Nolte S;
Eur J Cancer; 2024 Jun; 204():113927. PubMed ID: 38429166
[TBL] [Abstract][Full Text] [Related]
27. Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.
Norman R; Kemmler G; Viney R; Pickard AS; Gamper E; Holzner B; Nerich V; King M
Value Health; 2016 Dec; 19(8):1033-1038. PubMed ID: 27987630
[TBL] [Abstract][Full Text] [Related]
28. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
[TBL] [Abstract][Full Text] [Related]
29. EORTC QLQ-C30 general population normative data for the United States.
Rogge AA; Liegl G; Snyder C; Rose M; Nolte S;
Eur J Cancer; 2024 May; 202():114030. PubMed ID: 38552543
[TBL] [Abstract][Full Text] [Related]
30. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
31. Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment.
Finch AP; Gamper E; Norman R; Viney R; Holzner B; King M; Kemmler G;
Pharmacoeconomics; 2021 Sep; 39(9):1085-1098. PubMed ID: 34216380
[TBL] [Abstract][Full Text] [Related]
32. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis.
Kim H; Cook G; Goodall S; Liew D
Pharmacoecon Open; 2021 Sep; 5(3):459-467. PubMed ID: 33891268
[TBL] [Abstract][Full Text] [Related]
33. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study.
de Ligt KM; Aaronson NK; Liegl G; Nolte S;
Qual Life Res; 2023 Sep; 32(9):2477-2487. PubMed ID: 37031427
[TBL] [Abstract][Full Text] [Related]
34. Updated EORTC QLQ-C30 general population norm data for Germany.
Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
[TBL] [Abstract][Full Text] [Related]
35. Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Yang M; Vioix H; Hook ES; Hatswell AJ; Batteson RL; Gaumond BR; O'Brate A; Popat S; Paik PK
Value Health; 2023 Aug; 26(8):1155-1163. PubMed ID: 36805576
[TBL] [Abstract][Full Text] [Related]
36. General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
Pilz MJ; Loth FLC; Nolte S; Thurner AMM; Gamper EM; Anota A; Liegl G; Giesinger JM;
J Patient Rep Outcomes; 2024 May; 8(1):48. PubMed ID: 38695992
[TBL] [Abstract][Full Text] [Related]
37. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
38. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
[TBL] [Abstract][Full Text] [Related]
39. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
40. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
